← Back to Screener
ICU Medical Inc (ICUI)
Price$130.58
Favorite Metrics
Price vs S&P 500 (26W)5.12%
Price vs S&P 500 (4W)-5.82%
Market Capitalization$3.27B
P/E Ratio (Annual)4461.76x
All Metrics
P/CF (Annual)18.16x
Book Value / Share (Quarterly)$86.03
P/TBV (Annual)2.36x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-0.72%
Cash Flow / Share (Quarterly)$3.36
Price vs S&P 500 (YTD)-13.05%
Gross Margin (TTM)36.84%
Net Profit Margin (TTM)0.03%
EPS (TTM)$0.02
10-Day Avg Trading Volume0.26M
EPS Excl Extra (TTM)$0.02
Revenue Growth (5Y)11.91%
EPS (Annual)$0.03
ROI (Annual)0.02%
Gross Margin (Annual)36.84%
Net Profit Margin (5Y Avg)-0.33%
Cash / Share (Quarterly)$12.47
P/E Basic Excl Extra (TTM)4461.76x
Revenue Growth QoQ (YoY)-14.15%
EPS Growth (5Y)-62.61%
P/E Normalized (Annual)4461.76x
ROA (Last FY)0.02%
Revenue Growth TTM (YoY)-6.33%
EBITD / Share (TTM)$3.47
ROE (5Y Avg)-0.91%
Operating Margin (TTM)3.93%
Cash Flow / Share (Annual)$3.36
P/B Ratio1.54x
P/B Ratio (Quarterly)1.66x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.90x
Net Interest Coverage (TTM)1.05x
ROA (TTM)0.02%
EV / EBITDA (TTM)49.67x
EPS Incl Extra (Annual)$0.03
Current Ratio (Annual)2.39x
Quick Ratio (Quarterly)1.05x
3-Month Avg Trading Volume0.27M
52-Week Price Return-6.60%
EV / Free Cash Flow (Annual)51.29x
P/E Incl Extra (TTM)4461.76x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$60.36
P/S Ratio (Annual)1.46x
Asset Turnover (Annual)0.55x
52-Week High$160.29
Operating Margin (5Y Avg)2.84%
EPS Excl Extra (Annual)$0.03
CapEx CAGR (5Y)-0.68%
Tangible BV CAGR (5Y)2.69%
26-Week Price Return13.87%
Quick Ratio (Annual)1.05x
13-Week Price Return-12.50%
Total Debt / Equity (Annual)0.61x
Current Ratio (Quarterly)2.39x
Enterprise Value$4,248.533
Revenue / Share Growth (5Y)8.77%
Asset Turnover (TTM)0.54x
Book Value / Share Growth (5Y)3.86%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.35x
Pretax Margin (Annual)0.20%
Cash / Share (Annual)$12.47
3-Month Return Std Dev36.48%
Gross Margin (5Y Avg)34.43%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-3.68%
EBITDA Interim CAGR (5Y)-35.57%
ROE (Last FY)0.03%
Net Interest Coverage (Annual)1.05x
EPS Basic Excl Extra (Annual)$0.03
P/FCF (TTM)34.88x
Receivables Turnover (TTM)12.28x
EV / Free Cash Flow (TTM)51.29x
Total Debt / Equity (Quarterly)0.61x
EPS Incl Extra (TTM)$0.02
Receivables Turnover (Annual)12.28x
ROI (TTM)0.02%
P/S Ratio (TTM)1.46x
Pretax Margin (5Y Avg)-0.34%
Revenue / Share (Annual)$89.59
Tangible BV / Share (Annual)$60.36
Forward P/E16.16x
Free OCF CAGR (5Y)-7.51%
Price vs S&P 500 (52W)-41.69%
P/E Ratio (TTM)4461.76x
Year-to-Date Return-8.91%
5-Day Price Return0.49%
EPS Normalized (Annual)$0.03
ROA (5Y Avg)0.07%
Net Profit Margin (Annual)0.03%
Month-to-Date Return0.63%
Cash Flow / Share (TTM)$8.35
EBITD / Share (Annual)$3.43
Operating Margin (Annual)3.93%
LT Debt / Equity (Annual)0.60x
P/CF (TTM)18.16x
ROI (5Y Avg)0.06%
P/E Excl Extra (TTM)4461.76x
LT Debt / Equity (Quarterly)0.60x
EPS Basic Excl Extra (TTM)$0.02
P/TBV (Quarterly)2.36x
P/B Ratio (Annual)1.66x
Inventory Turnover (TTM)2.35x
Pretax Margin (TTM)0.20%
Book Value / Share (Annual)$86.03
Price vs S&P 500 (13W)-15.36%
Net Margin Growth (5Y)-66.24%
Beta0.82x
P/FCF (Annual)39.43x
Revenue / Share (TTM)$90.38
ROE (TTM)0.04%
52-Week Low$107.00
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.17
4.17
4.17
4.17
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ICUIICU Medical Inc | 1.46x | 11.91% | 36.84% | 3.93% | $130.58 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
ICU Medical is a pure-play infusion therapy company providing consumables, systems, and services across the full IV care continuum. The company has built top-tier market positions through strategic acquisitions, including Hospira Infusion Systems (2017) and Smiths Medical (2022), with revenues split across consumables (50%), infusion systems (30%), and vital care (20%). Over 60% of sales are generated in the United States.